ReviewFrontiers in microbiology2026
Bacteriophages in the environmental control of antimicrobial resistance: opportunities, risks, and surveillance challenges.
Review in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR) is a major global public health challenge, driven by the persistence and dissemination of antibiotic-resistant bacteria and antibiotic resistance genes (ARGs). These resistance determinants can accumulate and spread across diverse environmental compartments, including wastewater, hospital effluents, agricultural systems, and landfills, facilitating their dissemination through mechanisms such as horizontal gene transfer. Bacteriophages have emerged as promising tools for the targeted control of antibiotic-resistant bacterial populations, as their lytic activity can overcome conventional antibiotic resistance mechanisms and effectively target multidrug-resistant (MDR) and extensively drug-resistant (XDR) bacteria. In addition, phage-encoded enzymes, including endolysins and polysaccharide depolymerases, can disrupt bacterial cell structures and biofilms, further enhancing their potential as alternative antimicrobial strategies. However, the role of bacteriophages in AMR dynamics is inherently dual, as lytic phages can reduce antibiotic-resistant bacterial populations, whereas temperate phages may contribute to the dissemination of ARGs through transduction-mediated gene transfer. This duality represents an important biosafety concern that requires rigorous assessment before their large-scale application in environmental settings. This review critically examines the role of bacteriophages in addressing environmental antimicrobial resistance within a One Health framework. It first explores environmental ARG reservoirs and current surveillance approaches, followed by bacteriophage biology and mechanisms of action, their applications in clinical medicine, veterinary science, and environmental biocontrol, and finally the biological constraints and strategies to address these challenges. This work integrates environmental surveillance with phage-based intervention strategies to support the rational and responsible deployment of bacteriophages as complementary tools in the global response to AMR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.